We are live on ! Find out more
JGUA

John G. Ullman & Associates Portfolio holdings

AUM $754M
1-Year Est. Return 60.05%
This Fund
S&P 500
This Quarter Est. Return
+5.35%
1 Year Est. Return
+60.05%
3 Year Est. Return
+108.28%
5 Year Est. Return
+118.76%
10 Year Est. Return
+308.24%
AUM
$531M
AUM Growth
+$11.2M
Cap. Flow
-$11.3M
Cap. Flow %
-2.13%
Top 10 Hldgs %
33.37%
Holding
161
New
13
Increased
36
Reduced
86
Closed
16

Top Buys

Rank Stock Value
1
OGE icon
OGE Energy
OGE
+$2.24M
2
HAL icon
Halliburton
HAL
+$2.23M
3
CBI
Chicago Bridge & Iron Nv
CBI
+$2.21M
4
FCX icon
Freeport-McMoran
FCX
+$2.04M
5
BKNG icon
Booking.com
BKNG
+$1.78M

Sector Composition

Rank Sector Weight
1 Healthcare 25.33%
2 Industrials 20.74%
3 Technology 17.61%
4 Utilities 7.94%
5 Energy 7.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NVS icon
26
Novartis
NVS
$301B
$5.72M 1.08%
68,867
-1,507
-2% -$125K
DRC
27
DELISTED
DRESSER-RAND GROUP INC
DRC
$5.52M 1.04%
67,474
-1,725
-2% -$140K
AMGN icon
28
Amgen
AMGN
$210B
$5.41M 1.02%
33,943
-13,305
-28% -$2.07M
EWS icon
29
iShares MSCI Singapore ETF
EWS
$1.05B
$5.39M 1.02%
206,188
+17,025
+9% +$448K
MDT icon
30
Medtronic
MDT
$112B
$5.19M 0.98%
71,933
-1,250
-2% -$86.8K
POR icon
31
Portland General Electric
POR
$5.85B
$5.16M 0.97%
136,285
-2,800
-2% -$101K
TT icon
32
Trane Technologies
TT
$99.3B
$5.13M 0.97%
80,845
+13,825
+21% +$844K
EXC icon
33
Exelon
EXC
$48B
$5.04M 0.95%
190,504
-6,519
-3% -$167K
DUK icon
34
Duke Energy
DUK
$101B
$4.81M 0.91%
57,610
-19,274
-25% -$1.55M
OGE icon
35
OGE Energy
OGE
$9.92B
$4.68M 0.88%
131,855
+62,155
+89% +$2.24M
LLY icon
36
Eli Lilly
LLY
$1.09T
$4.59M 0.87%
66,588
-2,200
-3% -$148K
MMM icon
37
3M
MMM
$92.5B
$4.58M 0.86%
33,340
-7,923
-19% -$1.02M
AMAT icon
38
Applied Materials
AMAT
$358B
$4.54M 0.86%
182,210
-3,100
-2% -$70K
TMO icon
39
Thermo Fisher Scientific
TMO
$213B
$4.5M 0.85%
35,883
-67
-0.2% -$8.15K
EEMV icon
40
iShares MSCI Emerging Markets Min Vol Factor ETF
EEMV
$3.38B
$4.03M 0.76%
71,200
+20,900
+42% +$1.22M
TMP icon
41
Tompkins Financial
TMP
$1.42B
$4.01M 0.76%
72,545
-1,980
-3% -$97.8K
CYT
42
DELISTED
CYTEC INDS INC
CYT
$3.96M 0.75%
85,700
+10,950
+15% +$510K
ITRI icon
43
Itron
ITRI
$4.58B
$3.94M 0.74%
93,050
+5,100
+6% +$204K
ADI icon
44
Analog Devices
ADI
$175B
$3.92M 0.74%
70,626
-2,075
-3% -$106K
IXYS
45
DELISTED
IXYS Corp
IXYS
$3.74M 0.7%
297,015
+37,650
+15% +$424K
EMC
46
DELISTED
EMC CORPORATION
EMC
$3.5M 0.66%
117,795
-1,800
-2% -$52.4K
DIS icon
47
Walt Disney
DIS
$171B
$3.44M 0.65%
36,552
-600
-2% -$54.1K
XRAY icon
48
Dentsply Sirona
XRAY
$2.84B
$3.4M 0.64%
63,775
-2,900
-4% -$148K
ALTR
49
DELISTED
Altera Corp
ALTR
$3.31M 0.62%
89,600
+1,450
+2% +$51.3K
SIAL
50
DELISTED
SIGMA - ALDRICH CORP
SIAL
$3.29M 0.62%
23,983
-617
-3% -$83.8K

Similar funds

John G. Ullman & Associates's Q4 2014 Portfolio in Review

As of Q4 2014, John G. Ullman & Associates held 161 positions worth $531M, up 2.2% from $520M the previous quarter. Its ten largest holdings account for 33% of the portfolio.

John G. Ullman & Associates's Q4 2014 filing shows 13 new, 36 increased, 86 reduced and 16 closed positions. Its largest new stake was Halliburton: 45,734 shares worth $1.8M. The largest sale was Procter & Gamble, an estimated $3.77M.

By sector, the portfolio is most concentrated in Healthcare at 25% of assets, up from 25% a quarter earlier, followed by Industrials and Technology.

  • John G. Ullman & Associates's largest Q4 2014 buy was Halliburton: 45,734 shares worth $1.8M.
  • John G. Ullman & Associates added most to OGE Energy in Q4 2014, an estimated $2.24M increase.
  • John G. Ullman & Associates's biggest Q4 2014 reduction was Apple, cutting an estimated $3.52M.
  • John G. Ullman & Associates fully exited Procter & Gamble in Q4 2014, selling an estimated $3.77M.
  • John G. Ullman & Associates's ten largest holdings make up 33% of its $531M portfolio in Q4 2014.
  • John G. Ullman & Associates opened 13 new positions and closed 16 in Q4 2014.
  • John G. Ullman & Associates's portfolio value rose 2.2% quarter-over-quarter to $531M.

Based on John G. Ullman & Associates's 13F filing for Q4 2014, filed 26 Jan 2015.